Bentley’s passion is the development, manufacturing and marketing of innovative implants for minimal-invasive treatments of vascular diseases. Bentley was founded in 2009 by medical entrepreneurs Lars Sunnanväder and Miko Obradovic. The company has seen substantial growth since the launch of its first product in 2012. Since then Bentley rapidly expanded worldwide. Thanks to its international network of exclusive distribution partners Bentley is represented in more than 80 countries – in some even as market leader. Bentley is the only company worldwide that offers a covered balloon expandable stent to cardiologists, (endo-)vascular surgeons and interventional radiologists in a size range from 2.5 mm to 30 mm in diameter. The ten top-line products in Bentley’s portfolio are: • BeGraft coronary (2012) • BeGraft peripheral: first generation (2013); second generation (2015) • BeSmooth peripheral (2014) • BeGraft aortic (2016) • BeGraft peripheral PLUS (2017) • BeYond venous (2020) • BeBack crossing catheter (2023) • BeGraft (2025) • BeFlow iliac (2025) • BeFlared FEVAR (2025)
Looking for a particular Bentley employee's phone or email?
The Bentley annual revenue was $52.5 million in 2026.
Armin Kiser-Figuereo is the CEO Bentley Switzerland AG of Bentley.
201 people are employed at Bentley.
The NAICS codes for Bentley are [33, 339].
The SIC codes for Bentley are [384, 38].